Attorney Drug Ads Draw Criticism, But Little Action After House Hearing
Some lawmakers equated the drug ads to political advertisements, which may have a kernel of truth, but lack enough information to make a sound decision.
June 23, 2017 at 03:44 PM
7 minute read
Democratic lawmakers appeared reluctant Friday to further investigate drug ads by plaintiffs lawyers, though some Republicans, doctors and lawyers say the ads create serious health and safety problems.
In a hearing before the House Judiciary Subcommittee on the Constitution and Civil Justice, lawmakers sparred over whether lawyers' TV commercials highlighting negative side effects of certain drugs are unethical and warrant increased regulation. The ads are regulated by state bar associations, but some doctors, lawyers and business groups argue it's not enough because patients, frightened by the ads, sometimes stop taking their medication without consulting doctors. However, there have been few complaints of lawyer misconduct tied to the commercials.
“Today's hearing presents a new topic for us, but it's old wine in a new bottle,” said Rep. Steve Cohen, D-Tennessee. “It's another attack on trial lawyers … and the beneficiaries of this attack on the plaintiffs bar are well-heeled corporate interests that would benefit greatly and would prefer probably not to [have] attorneys at all unless they were on the defense side.”
Dr. Ilana Kutinsky, a cardiac electrophysiologist, and Dr. Shawn Fleming, a vascular surgeon, both testified about patients they've cared for who stopped taking drugs after seeing the ads. Kutinsky pointed out that older patients may already be frightened, and an ad can push them to stop taking medications.
The fight over attorney drug ads is another issue that deepens the rift between the defense bar and plaintiffs lawyers. Lisa Rickard, president of the U.S. Chamber of Commerce's Institute for Legal Reform, said Thursday the ads are “alarmist” and Congress is right to get involved. Committee Chairman Bob Goodlatte, D-Virginia, wrote letters to state bar associations in March urging them to require that ads include warnings to patients to consult a doctor before discontinuing medication. He also asked if complaints had been filed on the issue, though no association reported any.
During the hearing, the doctors suggested that consumers may not know how to file complaints, and also likely don't realize when they should. Attorney ethics expert and lawyer Lynda Shely said that anyone can submit a complaint over the ads, including doctors, and that hundreds of complaints are filed against lawyers every day. She added that it's not just consumers who complain, but also other lawyers.
Republicans also questioned whether attorneys should be held to a higher standard for false or misleading ads. Rep. Steve King, R-Iowa, likened the commercials to political ads, noting that even though there may be a “thread of truth” in them, they leave out “a whole ocean of information that's necessary to evaluate.”
King also questioned why, if doctors are liable for malpractice when they prescribe the wrong drug, attorneys are not liable for their ads.
“If the misinformation from attorneys brings about death or injury, and doctors are paying for their professional errors, why aren't attorneys paying for theirs?” King asked University of Oregon School of Law professor Elizabeth Tippett.
Tippett suggested lawyers may be liable under a common-law tort claim. Tippett, who advocated for greater self-regulation by attorneys, said that while the ads aren't necessarily untruthful, she was more concerned about the frightening tactics used in the commercials.
The Chamber's ILR released a survey this week that showed one in four Americans taking certain prescription medicines said they would stop immediately if they saw ads promoting lawsuits against the drug's manufacturer. A Republican polling firm, Public Opinion Strategies, conducted the survey.
Copyright the National Law Journal. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Related Articles:
|- Could Cymbalta Class Fall in Wake of High Court's 'Microsoft' Ruling?
- Labor, Civil Rights Lawyers Press Anti-Discrimination Claims Against Facebook
- FTC Tells Paid 'Influencers' to Disclose When Instagram Posts Are #Ads
Democratic lawmakers appeared reluctant Friday to further investigate drug ads by plaintiffs lawyers, though some Republicans, doctors and lawyers say the ads create serious health and safety problems.
In a hearing before the House Judiciary Subcommittee on the Constitution and Civil Justice, lawmakers sparred over whether lawyers' TV commercials highlighting negative side effects of certain drugs are unethical and warrant increased regulation. The ads are regulated by state bar associations, but some doctors, lawyers and business groups argue it's not enough because patients, frightened by the ads, sometimes stop taking their medication without consulting doctors. However, there have been few complaints of lawyer misconduct tied to the commercials.
“Today's hearing presents a new topic for us, but it's old wine in a new bottle,” said Rep. Steve Cohen, D-Tennessee. “It's another attack on trial lawyers … and the beneficiaries of this attack on the plaintiffs bar are well-heeled corporate interests that would benefit greatly and would prefer probably not to [have] attorneys at all unless they were on the defense side.”
Dr. Ilana Kutinsky, a cardiac electrophysiologist, and Dr. Shawn Fleming, a vascular surgeon, both testified about patients they've cared for who stopped taking drugs after seeing the ads. Kutinsky pointed out that older patients may already be frightened, and an ad can push them to stop taking medications.
The fight over attorney drug ads is another issue that deepens the rift between the defense bar and plaintiffs lawyers. Lisa Rickard, president of the U.S. Chamber of Commerce's Institute for Legal Reform, said Thursday the ads are “alarmist” and Congress is right to get involved. Committee Chairman Bob Goodlatte, D-Virginia, wrote letters to state bar associations in March urging them to require that ads include warnings to patients to consult a doctor before discontinuing medication. He also asked if complaints had been filed on the issue, though no association reported any.
During the hearing, the doctors suggested that consumers may not know how to file complaints, and also likely don't realize when they should. Attorney ethics expert and lawyer Lynda Shely said that anyone can submit a complaint over the ads, including doctors, and that hundreds of complaints are filed against lawyers every day. She added that it's not just consumers who complain, but also other lawyers.
Republicans also questioned whether attorneys should be held to a higher standard for false or misleading ads. Rep. Steve King, R-Iowa, likened the commercials to political ads, noting that even though there may be a “thread of truth” in them, they leave out “a whole ocean of information that's necessary to evaluate.”
King also questioned why, if doctors are liable for malpractice when they prescribe the wrong drug, attorneys are not liable for their ads.
“If the misinformation from attorneys brings about death or injury, and doctors are paying for their professional errors, why aren't attorneys paying for theirs?” King asked
Tippett suggested lawyers may be liable under a common-law tort claim. Tippett, who advocated for greater self-regulation by attorneys, said that while the ads aren't necessarily untruthful, she was more concerned about the frightening tactics used in the commercials.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View AllDelivery of Legal Services Is Changing as More States Explore Reform Measures
Coalition of AGs Support Updates to ABA's Legal Education Diversity Standard
3 minute readSotomayor, Speaking With Civics Students, Eyes AI's Impact on Law
Uniform Bar Admissions Rule for US Trial Courts Draws Opposition from Circuit, District Judges
Trending Stories
- 1Judge Denies Sean Combs Third Bail Bid, Citing Community Safety
- 2Republican FTC Commissioner: 'The Time for Rulemaking by the Biden-Harris FTC Is Over'
- 3NY Appellate Panel Cites Student's Disciplinary History While Sending Negligence Claim Against School District to Trial
- 4A Meta DIG and Its Nvidia Implications
- 5Deception or Coercion? California Supreme Court Grants Review in Jailhouse Confession Case
Who Got The Work
Michael G. Bongiorno, Andrew Scott Dulberg and Elizabeth E. Driscoll from Wilmer Cutler Pickering Hale and Dorr have stepped in to represent Symbotic Inc., an A.I.-enabled technology platform that focuses on increasing supply chain efficiency, and other defendants in a pending shareholder derivative lawsuit. The case, filed Oct. 2 in Massachusetts District Court by the Brown Law Firm on behalf of Stephen Austen, accuses certain officers and directors of misleading investors in regard to Symbotic's potential for margin growth by failing to disclose that the company was not equipped to timely deploy its systems or manage expenses through project delays. The case, assigned to U.S. District Judge Nathaniel M. Gorton, is 1:24-cv-12522, Austen v. Cohen et al.
Who Got The Work
Edmund Polubinski and Marie Killmond of Davis Polk & Wardwell have entered appearances for data platform software development company MongoDB and other defendants in a pending shareholder derivative lawsuit. The action, filed Oct. 7 in New York Southern District Court by the Brown Law Firm, accuses the company's directors and/or officers of falsely expressing confidence in the company’s restructuring of its sales incentive plan and downplaying the severity of decreases in its upfront commitments. The case is 1:24-cv-07594, Roy v. Ittycheria et al.
Who Got The Work
Amy O. Bruchs and Kurt F. Ellison of Michael Best & Friedrich have entered appearances for Epic Systems Corp. in a pending employment discrimination lawsuit. The suit was filed Sept. 7 in Wisconsin Western District Court by Levine Eisberner LLC and Siri & Glimstad on behalf of a project manager who claims that he was wrongfully terminated after applying for a religious exemption to the defendant's COVID-19 vaccine mandate. The case, assigned to U.S. Magistrate Judge Anita Marie Boor, is 3:24-cv-00630, Secker, Nathan v. Epic Systems Corporation.
Who Got The Work
David X. Sullivan, Thomas J. Finn and Gregory A. Hall from McCarter & English have entered appearances for Sunrun Installation Services in a pending civil rights lawsuit. The complaint was filed Sept. 4 in Connecticut District Court by attorney Robert M. Berke on behalf of former employee George Edward Steins, who was arrested and charged with employing an unregistered home improvement salesperson. The complaint alleges that had Sunrun informed the Connecticut Department of Consumer Protection that the plaintiff's employment had ended in 2017 and that he no longer held Sunrun's home improvement contractor license, he would not have been hit with charges, which were dismissed in May 2024. The case, assigned to U.S. District Judge Jeffrey A. Meyer, is 3:24-cv-01423, Steins v. Sunrun, Inc. et al.
Who Got The Work
Greenberg Traurig shareholder Joshua L. Raskin has entered an appearance for boohoo.com UK Ltd. in a pending patent infringement lawsuit. The suit, filed Sept. 3 in Texas Eastern District Court by Rozier Hardt McDonough on behalf of Alto Dynamics, asserts five patents related to an online shopping platform. The case, assigned to U.S. District Judge Rodney Gilstrap, is 2:24-cv-00719, Alto Dynamics, LLC v. boohoo.com UK Limited.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250